HeLa-I.jpgThe Bioexpression and Fermentation Facility is participating in a cancer reproducibility study in cooperation with Science Exchange and the Center for Open Science.  Many labs have been involved and a report from NPR suggests that there are problems with reproducing work done in the original study.  As described in the NPR report, previously, Amgen and Bayer had reported issues with reproducibility.  The Cancer Reproducibility Study was developed to further evaluated those findings with the goal of "Through independent direct replication studies, the project aims to identify best practices that maximize reproducibility and facilitate an accurate accumulation of knowledge, enabling potentially impactful novel findings to be effectively built upon by the scientific community."  Results from these studies are starting to be published in the journal eLife.